...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: BIO CEO Schedule Out

https://bioceoandinvestorconference19.azurewebsites.net/

Resverlogix Tuesday Feb 12th 2:00 to 2:15 PM

Zenith Tuesday Feb 12th 2:30 to 2:45 PM

Thanks forĀ posting over on IV rndtbl.

Share
New Message
Please login to post a reply